Relacorilant
id:
relacorilant-184-17689850
title:
Relacorilant
text:
Relacorilant is an antiglucocorticoid which is under development by Corcept Therapeutics for the treatment of Cushing's syndrome. It is also under development for the treatment of solid tumors and alcoholism. The drug is a nonsteroidal compound and acts as an antagonist of the glucocorticoid receptor. As of December 2017, it is in phase II clinical trials for Cushing's syndrome and phase I/II clinical studies for solid tumors, while the clinical phase for alcoholism is unknown.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Relacorilant
date created:
2017-12-21T16:33:54Z
date modified:
2024-09-07T15:14:49Z
main entity:
{"identifier":"Q48845466","url":"https://www.wikidata.org/entity/Q48845466"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0b/Relacorilant.svg","width":696,"height":776}
fields total:
13
integrity:
16